Your browser doesn't support javascript.
loading
Gram-negative bacillary bacteremia in human immunodeficiency virus type 1-infected children.
Rongkavilit, C; Rodriguez, Z M; Gómez-Marín, O; Scott, G B; Hutto, C; Rivera-Hernandez, D M; Mitchell, C D.
Affiliation
  • Rongkavilit C; Department of Pediatrics, University of Miami School of Medicine, FL, USA.
Pediatr Infect Dis J ; 19(2): 122-8, 2000 Feb.
Article de En | MEDLINE | ID: mdl-10693998
ABSTRACT

BACKGROUND:

HIV-infected children are particularly susceptible to serious bacterial infections including Gram-negative bacillary bacteremia (GNB). However, the information available on GNB in these children is limited.

METHODS:

Retrospective review of hospital charts of HIV-infected children with GNB diagnosed between 1980 and 1997. The association between bacteremic episodes, degree of immunosuppression, HIV severity, medical treatment and clinical outcome was assessed.

RESULTS:

Of 680 HIV-infected children, 72 (10.6%) had 95 episodes of GNB. Statistical analyses were restricted to data from the first episode. The mean age (+/-SD) at diagnosis of GNB was 2.5 +/- 2.7 years (median, 1.6). The predominant organisms were Pseudomonas aeruginosa (26.4%), nontyphoidal Salmonella (15.3%), Escherichia coli (15.3%) and Haemophilus influenzae (12.5%). The relative frequency, per 5-year interval, of P. aeruginosa bacteremia steadily increased from 13% during 1980 through 1984 to 56% during 1995 through 1997. There were no cases of H. influenzae bacteremia after January 1, 1990. Eighty percent of GNB developed in children with AIDS and 72.2% developed in those with severe immunosuppression. Hypogamma-globulinemia and neutropenia were present in only 4.9 and 10.4% of first episodes, respectively. The overall case-fatality rate of GNB was 43.0%, and in children younger than 12 months it was 54.2%.

CONCLUSIONS:

A diagnosis of AIDS and/or severe immunosuppression was associated with increased risk of GNB, especially among younger children. Because of the high mortality of GNB, a broad spectrum antimicrobial therapy that effectively covers these organisms should be promptly instituted when bacteremia is suspected in HIV-infected children.
Sujet(s)
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à VIH / VIH-1 (Virus de l'Immunodéficience Humaine de type 1) / Infections bactériennes à Gram négatif / Bactériémie Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Child / Child, preschool / Humans / Infant Langue: En Journal: Pediatr Infect Dis J Sujet du journal: DOENCAS TRANSMISSIVEIS / PEDIATRIA Année: 2000 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à VIH / VIH-1 (Virus de l'Immunodéficience Humaine de type 1) / Infections bactériennes à Gram négatif / Bactériémie Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Child / Child, preschool / Humans / Infant Langue: En Journal: Pediatr Infect Dis J Sujet du journal: DOENCAS TRANSMISSIVEIS / PEDIATRIA Année: 2000 Type de document: Article Pays d'affiliation: États-Unis d'Amérique